ICCM
Icecure MedicalFNasdaq / Health Care Equipment & Services
Last Price
At close
2026-07-22
Current thesis
Positive clinical readouts and signed distribution agreements restore confidence; modest revenue growth and improved margins could re-rate the stock toward small-cap medtech peers.
Posture
Defensive
Lead driver
Value
What changed
Value remains the lead driver in the composite, 7D delta +0.0.
What can break
Clinical or regulatory setbacks for cryoablation devices
Momentum
21
Value
37
Sentiment
26
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $0.14 · Bull $0.22 · Bear $0.07
Data freshness
Prices
As of 2026-07-22
Fundamentals
As of 2026-07-21 • Vendor: Data Vendor v1
Scores
As of 2026-07-22 • Model: HYBRID_IC_RP
AI Memo
As of 2025-11-04 • Model: RankAlpha Sentiment AI
Investment thesisAs of 2026-07-22
Investment thesis
As of 2026-07-22
Supporting evidence
What
Grade F · Defensive
Confidence Medium · Net Neutral
Target $30.50
Why
Momentum21 · Δ7d -
Value37 · Δ7d +0.0
Sentiment26 · Δ7d -
So what
Weak posture (Net Neutral). Prioritize risk control and patience.
Lead driver: Value · See fundamentals
Momentum
21
26% active weight
Current posture
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Value
37
39% active weight
Current posture
7d trendFlat
Δ7d
+0.0
Δ21d
+0.1
Sentiment
26
34% active weight
Current posture
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Why this grade
Composite grade F. Momentum 21.3 / Value 36.5 / Sentiment 26.0
Fundamentals (TTM)As of 2026-07-21
Fundamentals (TTM)
As of 2026-07-21
Market Cap
$9.43M
Beta
2.28
Shares Out
2.81M
P/E (TTM) · Derived
-0.5
P/S (TTM)
15.07
P/FCF (TTM) · Derived
-0.49
Rev YoY
+25.7%
EPS YoY
-4.9%
Gross Margin
+36.5%
Op Margin
-517.7%
Net Debt
-$8.68M
Current Ratio
2.52
As of 2026-07-22 • Updated nightlySource: Internal modelMethodology